Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma-Reference-Cited by-同舟云学术

Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma

Published:2022-01 Issue:1 Volume:15 Page:101240
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Golinelli Giulia,Grisendi Giulia,Dall'Ora Massimiliano,Casari Giulia,Spano Carlotta,Talami Rebecca,Banchelli Federico,Prapa Malvina,Chiavelli Chiara,Rossignoli Filippo,Candini Olivia,D'Amico Roberto,Nasi Milena,Cossarizza Andrea,Casarini Livio,Dominici Massimo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference61 articles.

1. Exploiting signaling pathways and immune targets beyond the standard of care for Ewing sarcoma;Casey;Front Oncol,2019

2. Ewing's sarcoma origin: from duel to duality;Riggi;Expert Rev Anticancer Ther,2009

3. Molecular pathogenesis of ewing sarcoma: new therapeutic and transcriptional targets;Lessnick;Ann. Rev. Pathol. Mech. Dis.,2012

4. Primary disseminated multifocal ewing sarcoma: results of the euro-ewing 99 trial;Ladenstein;J. Clin. Oncol.,2010

5. Ewing sarcoma: current management and future approaches through collaboration;Gaspar;J. Clin. Oncol.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Death Receptor 5 (DR5) for imaging and treatment of primary bone and soft tissue tumors: an update of the literature;Frontiers in Molecular Biosciences;2024-09-02

2. An anti-GD2 aptamer-based bifunctional spherical nucleic acid nanoplatform for synergistic therapy targeting MDM2 for retinoblastoma;Biomedicine & Pharmacotherapy;2024-05

3. CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies;Frontiers in Immunology;2024-04-12

4. Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off‐the‐shelf versatile tumor delivery vehicle;Medicinal Research Reviews;2024-02

5. Biology of GD2 ganglioside: implications for cancer immunotherapy;Frontiers in Pharmacology;2023-08-21